In early 2024, I was diagnosed with diffuse large B-cell lymphoma (DLBCL) and had already relapsed twice. My doctor in Kuala Lumpur told me CAR-T was the only option, but only two centers in Malaysia offer it, with a six-month-plus wait.
Through MyMedVia, I was matched with Dr. Zhang Minghua and his team at Sun Yat-sen University Cancer Center in Guangzhou within three weeks. From medical-record translation and visa processing to full in-country accompaniment, the efficiency exceeded expectations.
Cell collection → manufacturing → infusion — the entire process was completed in 42 days. Now, 12 months later, a PET-CT scan shows complete remission (CR) with no signs of relapse.
Medical advisor reply within 24 hours · Free consultation